$58.38
▼ $-0.12
(-0.21%)
Vol 1.0M
2
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$6.0B
ROE
-21.1%
D/E
0.00
Beta
1.33
52W
$28–$94
Wall Street Consensus
17 analysts · Apr 20267
Strong Buy
8
Buy
2
Hold
0
Sell
0
Strong Sell
88.2%
Buy Rating
Price Chart
Similar Stocks
EXEL
Exelixis Inc
P/E 17.3
$11.8B
BMRN
BioMarin Pharmaceutical Inc
P/E 21.9
$11.4B
PRAX
Praxis Precision Medicines Inc
$7.4B
ARWR
Arrowhead Pharmaceuticals Inc
$9.0B
CYTK
Cytokinetics Inc
$7.8B
NUVL
Nuvalent, Inc
$7.3B
KRYS
Krystal Biotech Inc
P/E 35.9
$7.1B
HALO
Halozyme Therapeutics Inc
P/E 13.3
$7.9B
Earnings
Beat rate: 25.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $-1.55 | $-1.80 | $-0.25 |
| Sep 2025 | $-1.29 | $-1.56 | $-0.27 |
| Jun 2025 | $-1.19 | $-1.22 | $-0.03 |
| Mar 2025 | $-1.07 | $-1.04 | +$0.03 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -16.9% | -16.9% | -16.9% | -16.9% | -21.1% | -21.1% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 11.11 | 11.11 | 11.11 | 11.11 | 8.83 | 8.83 |
Key Ratios
ROA (TTM)
-19.7%
P/B
3.1
EPS (TTM)
$-4.84
CF/Share
$-3.25
52W High
$93.77
52W Low
$27.66
$27.66
52-Week Range
$93.77
How does PCVX compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
PCVX valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
3.1
▲
25%
above
peers
(2.5)
vs Peers
vs Industry
Pricier
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
PCVX profitability vs Biotechnology peers
ROE
-21.1%
▲
69%
above
peers
(-67.3%)
vs Peers
vs Industry
Top tier
Net margin
—
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-19.7%
▲
58%
above
peers
(-46.7%)
vs Peers
vs Industry
Top tier
PCVX financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
8.8
▲
99%
above
peers
(4.4)
vs Peers
vs Industry
Strong liquidity
Beta
1.3
▲
37%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
PCVX fundamentals radar
PCVX
Peer median
Industry
PCVX profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio